Skip to main content
Clinical Trials/NL-OMON34145
NL-OMON34145
Completed
Not Applicable

Randomized study to assess the effect of thrombus aspiration on flow area in STEMI patients: an Optical Frequency Domain Imaging (OFDI) study - TROFI

Terumo0 sites70 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myoccardial infarction
Sponsor
Terumo
Enrollment
70
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Terumo

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient is at least 18 years of age
  • 2\. Patients with ST\-segment elevation Myocardial Infarction documented in an ambulance or in a Cathlab, with \>\=2 mm ST segment elevation in at least two contiguous leads, presenting in the Cathlab \<12 hours after the onset of symptoms lasting \>\=20 min and having an angiographically visible stenosis (\>30%) or TIMI\<\= II in de\-novo, native, previously unstented vessel
  • 3\. The single vessel coronary artery disease
  • 4\. Signed Informed Consent
  • 5\. The patient understands and accepts clinical follow\-up and OFDI controls.
  • 6\. Patients residence is in the area covered by hospital
  • 7\.Vessel size should match available Nobori stent sizes (\<4\.0 mm, and \>2\.0 mm by visual assessment)

Exclusion Criteria

  • 1\. Pregnancy
  • 2\. Known intolerance to aspirin, clopidogrel, heparin, stainless steel, Biolimus A9, contrast
  • 3\. Diameter Stenosis \<30% in the target lesion
  • 4\. The multi\-vessel coronary artery disease (DS\>50%)
  • 5\. Unprotected left main coronary artery stenosis \>30% by visual assessment
  • 6\. Distal vessel occlusion
  • 7\. Severe tortuous, calcified or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub\-optimal imaging or excessive risk of complication from placement of an OFDI catheter
  • 8\. Fibrinolysis prior to PCI
  • 9\. Known thrombocytopaenia (PLT\< 100,000/mm3\)
  • 10\. Contraindications to PCI, stenting, ASA, clopidogrel

Outcomes

Primary Outcomes

Not specified

Similar Trials